BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
©The Author(s) 2025.
World J Virol. Sep 25, 2025; 14(3): 111071
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.111071
Table 2 Demographics of eligible studies reported in the narrative review (n = 68), excluding two studies[80,81]
Studies
Mean/median/n (SD/IQR/%)
Number of reported studies (%)
Total participants5350468
Sample of older participants (100 or less)-12 (22.64)
Median age, years51.0 (11.0)59
Age group1
    Younger age (< 50 years)31519 (67.44)53
    Older age (≥ 50 years)15216 (32.56)53
Sex1
    Female15338 (31.75)62
    Male32965 (68.25)62
Race1
    White14126 (43.95)46
    Black11805 (36.73)33
    Other6210 (19.32)33
Education levels1
    High school or less 25257 (59.47)41
    College (some years) or higher 17212 (40.53)36
Employed1
    Yes7175 19
Risk of exposures1
    Homosexual 12706 (53.62)25
    Drug use6387 (26.96)17
    Heterosexual4075 (17.20)14
HIV status1
    Median time (years) since known HIV diagnosis 17.0 (10.0)32
    Median current CD4 T-cells618 (74)17
     Median lowest CD4 T-cells 245 (202)12
    A history of AIDS diagnosis 5,259 17
Mean summary scores of MOS-HIV
    Physical-HRQoL53.85 (9.43)13
    Mental-HRQoL51.54 (9.81)13
Studies included only2
    Older people6289 (41.33)21
    Older females1966 (12.82)4
    Older non-heterosexual individuals910 (60.60)6
Study years
    1995-2010-7 (10.29)
    2011-2015-22 (32.25)
    2016-2020 -33 (48.53)
    2021-2022 -6 (8.82)
Study places
    North America region-38 (55.88)
    Europe region-13 (19.12)
    Others-17 (25.00)


Write to the Help Desk